The following are excerpts from the newsletter

• Intimidation: Practitioners speak up about this unresolved problem (Part I)
• Why there may be increased risk of dosing errors with KINERET (anakinra).
• How to express large doses more safely.
• Why products, such as ethyl chloride spray, should be handled with extreme caution.
• Confusion between AVINZA (morphine extended release) and EVISTA (raloxiene).
• Confusion between THAM (tromethamine) and TORADOL (ketorolac).
• ISMP's next teleconference "A Real-Life View of the Medication/Patient Safety Specialist".
• Free Medication-related FDA Patient Safety videos provided in cooperation with ISMP
• The winners and honorable mentions in ISMP's Patient Safety Contest
  

March 25, 2004

• Intimidation: Practitioners speak up about this unresolved problem (Part II)
• The recall on oxymetazoline nasal spray by CDC.
• Confusion between BICILLIN products puts hundreds of patients at risk.
• Child harmed with potassium chloride given IV push.
• How to avoid confusion between PROTONIX (pantoprazole), PROTEINEX (protein hydrolisate), and protamine.
• How to implement JC's prohibited abbreviation requirement.
• How ISMP's alerts help avoid methotrexate errors.
• More on difficulties with implantable pumps.

…then see the full text version of our newsletter by subscribing now.